Publications

Journal Article
Research Support, Non-U.S. Gov't
Ppublish 5 citations
Electronic publication date
March 22, 2014

View on Pubmed.gov 23407996 | View on doi.org 10.1007/s10753-...

Low-dose interferon-α treatment improves survival and inflammatory responses in a mouse model of fulminant acute respiratory distress syndrome.

Search for publications in this journal Inflammation - 36(4):812-20

Abstract

Acute respiratory distress syndrome (ARDS) is accompanied by severe lung inflammation induced by various diseases. Despite the severity of symptoms, therapeutic strategies for this pathologic condition are still poorly developed. Interferon (IFN)-α is well known as an antiviral cytokine and low-dose IFN-α has been reported to show antiinflammatory effects. Therefore, we investigated how this cytokine affected ARDS in a mouse model. C57BL/6 mice received sequential intratracheal administration of α-galactosylceramide (α-GalCer) and lipopolysaccharide (LPS), which resulted in the development of fulminant ARDS. These mice were then treated intranasally with IFN-α and their survival, lung weight, pathological findings, and cytokine production were evaluated. Administration of low-dose IFN-α prolonged survival of fulminant ARDS mice, but higher doses of IFN-α did not. Histological analysis showed that low-dose IFN-α treatment improved findings of diffuse alveolar damage in fulminant ARDS mice, which was associated with reduction in the wet/dry (W/D) lung weight ratio. Furthermore, IFN-γ production in the lungs was significantly reduced in IFN-α-treated mice, compared with control mice, but tumor necrosis factor (TNF)-α production was almost equivalent for both groups. Low-dose IFN-α shows antiinflammatory and therapeutic effects in a mouse model of fulminant ARDS, and reduced production of IFN-γ in the lung may be involved in the beneficial effect of this treatment.

References

J Interferon Cytokine Res. 2005 Apr;25(4):202-8

Antiviral Res. 2006 Sep;71(2-3):108-16

J Interferon Cytokine Res. 2009 Apr;29(4):241-7

Dis Model Mech. 2009 May-Jun;2(5-6):218-23

Cited by 5 citations (total)

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Review

The Role of Type I IFNs in Influenza: Antiviral Superheroes or Immunopathogenic Villains?

Electronic publication date August 31, 2021

Search for publications in this journal J Innate Immun

Wenxin Wu [...] Jordan P Metcalf et al.

The important role of interferons (IFNs) in antiviral innate immune defense is well established. Although recombinant IFN-α was approved for...

Journal Article Review

Potential Prophylactic Treatments for COVID-19.

Electronic publication date August 31, 2021

Search for publications in this journal Viruses

Noam Ben-Zuk [...] Yoav Gal et al.

The World Health Organization declared the SARS-CoV-2 outbreak a Public Health Emergency of International Concern at the end of January...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances